Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer
Clinical trial NCT04305236 · TERMINATED
Trial details
- NCT number
- NCT04305236
- Sponsor
- University of California, Irvine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-23
- Primary completion
- 2022-02-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.